We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Anti-influenza Agents Inspired by Immunotherapy

Industry Insight   Jun 13, 2019

Anti-influenza Agents Inspired by Immunotherapy

Cloudbreak Antiviral Conjugates (AVCs) are not conventional antibody-drug conjugates (ADCs). Left: Oncology ADC using an antibody to deliver a toxic payload to a cancer cell. Right: Cloudbreak antiviral Fc conjugates (AVCs) use a novel antiviral drug (TM) to provide direct pathogen killing and to deliver an Fc antibody fragment domain (EM) to a pathogen for a focused immune response. Credit: Cidara Therapeutics

Michele Wilson PhD

Science Writer


Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free